Development of human monoclonal antibodies to diphtheria toxin: A solution for the increasing lack of equine DAT for therapeutic use?

Virulence

Volumn 7, Issue 6, 2016, Pages 613-615

  Huygen, Kris ^a  

^a SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

Author keywords

diphtheria; equine diphtheria antitoxin

Indexed keywords

DIPHTHERIA ANTIBODY; DIPHTHERIA TOXIN; DIPHTHERIA VACCINE; HUMAN MONOCLONAL ANTIBODY; HUMAN MONOCLONAL IGG1 ANTI DIPHTHERIA TOXIN ANTIBODY; RECOMBINANT ANTIBODY; UNCLASSIFIED DRUG; MONOCLONAL ANTIBODY;

ANTIBODY BLOOD LEVEL; DIPHTHERIA; HUMAN; NONHUMAN; NOTE; SERUM SICKNESS; SYMPTOM ASSESSMENT; VACCINATION; ANIMAL; HORSE;

ANIMALS; ANTIBODIES, MONOCLONAL; DIPHTHERIA; DIPHTHERIA ANTITOXIN; DIPHTHERIA TOXIN; HORSES; HUMANS;

EID: 84973624949     PISSN: 21505594     EISSN: 21505608     Source Type: Journal    
DOI: 10.1080/21505594.2016.1190062     Document Type: Note

References (11)

1. K.S.Wagner, J.M.White, I.Lucenko, D.Mercer, N.S.Crowcroft, S.Neal, A.Efstratiou. Diphtheria in the postepidemic period, Europe, 2000-2009. Emerg Infect Dis 2012; 18:217–225; PMID:22304732; http://dx.doi.org/10.3201/eid1802.110987
2. K.S.Wagner, P.Stickings, J.M.White, S.Neal, N.S.Crowcroft, D.Sesardic, A.Efstratiou. A review of the international issues surrounding the availability and demand for diphtheria antitoxin for therapeutic use. Vaccine 2009; 28:14–20; PMID:19818425; http://dx.doi.org/10.1016/j.vaccine.2009.09.094
3. M.Kakita, T.Takahashi, T.Komiya, Y.Iba, T.Tsuji, Y.Kurosawa, M.Takahashi. Isolation of a human monoclonal antibody with strong neutralizing activity against diphtheria toxin. Infect Immun 2006; 74:3682–3; PMID:16714603; http://dx.doi.org/10.1128/IAI.01731-05
4. L.M.Sevigny, B.J.Booth, K.J.Rowley, B.A.Leav, P.S.Cheslock, K.A.Garrity, S.E.Sloan, W.Thomas, Jr., G.J.Babcock, Y.Wang. Identification of a human monoclonal antibody to replace equine diphtheria antitoxin for treatment of diphtheria intoxication. Infect Immun 2013; 81:3992–4000; PMID:23940209; http://dx.doi.org/10.1128/IAI.00462-13
5. H.L.Smith, P.Cheslock, M.Leney, B.Barton, D.C.Molrine. Potency of a human monoclonal antibody to diphtheria toxin relative to equine diphtheria antitoxin in a guinea pig intoxication model. Virulence 2016; 7(x):xx-xx;PMID:27070129; http://dx.doi.org/10.1080/21505594.2016.1171436
6. D.W.Scheifele, J.J.Ochnio. The immunological basis for immunization series/module 2:diphtheria update 2009. [pp. 1-28]; WHO.
7. W.J.Edmunds, R.G.Pebody, H.Aggerback, S.Baron, G.Berbers, M.A.Conyn-Van Spaendonck, H.O.Hallander, R.Olander, P.A.Maple, H.E.Melker, et al. The sero-epidemiology of diphtheria in Western Europe. ESEN Project. Epidemiol Infect 2000; 125:113–25; PMID:11057967; http://dx.doi.org/10.1017/S0950268899004161
8. H.Theeten, V.Hutse, N.Hens, Y.Yavuz, K.Hoppenbrouwers, P.Beutels, R.Vranckx, P.Van Damme. Are we hitting immunity targets? The 2006 age-specific seroprevalence of measles, mumps, rubella, diphteria and tetanus in Belgium. Epidemiol Infect 2011; 139:494–504; PMID:20587123; http://dx.doi.org/10.1017/S0950268810001536
9. E.M.Swart, P.G.van Gageldonk, H.E.de Melker, F.R.van der Klis, G.A.Berbers, L.Mollema. Long-term protection against diphtheria in the Netherlands after 50 years of vaccination:results from a seroepidemiological study. PLoS One 2016; 11:e0148605; PMID:26863307; http://dx.doi.org/10.1371/journal.pone.0148605
10. K.Huygen, R.N.Caboré, K.Maertens, P.Van Damme, E.Leuridan. Humoral and cell mediated immune responses to a pertussis vaccine in pregnant and nonpregnant women. Vaccine 2015; 33:4117–23; PMID:26187257; http://dx.doi.org/10.1016/j.vaccine.2015.06.108
11. K.Maertens, R.N.Caboré, K.Huygen, N.Hens, P.Van Damme, E.Leuridan. Pertussis vaccination during pregnancy in Belgium:Results of a prospective controlled cohort study. Vaccine 2016; 34:142–150; PMID:26592142; http://dx.doi.org/10.1016/j.vaccine.2015.10.100